{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:26:56Z","timestamp":1747308416132},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2002,6,24]],"date-time":"2002-06-24T00:00:00Z","timestamp":1024876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,6,24]],"date-time":"2002-06-24T00:00:00Z","timestamp":1024876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/rr183","type":"journal-article","created":{"date-parts":[[2002,9,26]],"date-time":"2002-09-26T12:07:27Z","timestamp":1033042047000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing"],"prefix":"10.1186","volume":"3","author":[{"given":"Jan LL","family":"Kimpen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,6,24]]},"reference":[{"key":"183_CR1_183","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3928\/0090-4481-19900901-09","volume":"19","author":"WP Glezen","year":"1990","unstructured":"Glezen WP: Morbidity associated with the major respiratory viruses.\nPediatr Ann 1990, 19:535\u2013542.","journal-title":"Pediatr Ann"},{"key":"183_CR2_183","first-page":"1782","volume-title":"In Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 5th ed, vol. 2","author":"CB Hall","year":"2000","unstructured":"Hall CB, McCarthy CA: Respiratory syncytial virus.\nIn Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 5th ed, vol. 2.\n(Edited by: Mandell GL, Bennett JE, Dolin R). Philadelphia: Churchill Livingstone 2000, 1782\u20131801."},{"key":"183_CR3_183","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1056\/NEJM200106213442507","volume":"344","author":"CB Hall","year":"2001","unstructured":"Hall CB: Respiratory syncytial virus and parainfluenza virus.\nN Engl J Med 2001, 344:1917\u20131928.","journal-title":"N Engl J Med"},{"key":"183_CR4_183","first-page":"1501","volume-title":"In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 4th ed","author":"CB Hall","year":"1995","unstructured":"Hall CB, McCarthy CA: Respiratory syncytial virus.\nIn Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 4th ed.\n(Edited by: Mandell GL, Bennett JE, Dolin R). New York: Churchill Livingstone 1995, 1501\u20131519."},{"key":"183_CR5_183","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/00006454-200103000-00012","volume":"20","author":"L Bont","year":"2001","unstructured":"Bont L, van Aalderen WMC, Versteegh J, Brus F, Draaisma JTM, Pekelharing-Berghuis M, van Diemen-Steenvoorde RAAM, Kimpen JLL: Airflow limitation during respiratory syncytial virus lower respiratory tract infection predicts recurrent wheezing.\nPediatr Infect Dis J 2001, 20:277\u2013282.","journal-title":"Pediatr Infect Dis J"},{"key":"183_CR6_183","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(98)10321-5","volume":"354","author":"RT Stein","year":"1999","unstructured":"Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD: Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.\nLancet 1999, 354:541\u2013545.","journal-title":"Lancet"},{"key":"183_CR7_183","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1164\/ajrccm.161.5.9906076","volume":"161","author":"N Sigurs","year":"2000","unstructured":"Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B: Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.\nAm J Respir Crit Care Med 2000, 161:1501\u20131507.","journal-title":"Am J Respir Crit Care Med"},{"key":"183_CR8_183","first-page":"299","volume-title":"In New Vaccine Development: Establishing Priorities. Volume 2: Diseases of Importance in Developing Countries. Washington, DC: National Academy Press;","author":"SL Katz","year":"1986","unstructured":"Katz SL, Beale J, Becker MH, Chin J: The prospects for immunizing against respiratory syncytial virus.\nIn New Vaccine Development: Establishing Priorities. Volume 2: Diseases of Importance in Developing Countries. Washington, DC: National Academy Press; 1986, 299\u2013308."},{"key":"183_CR9_183","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1164\/ajrccm.161.5.9904078","volume":"161","author":"L Bont","year":"2000","unstructured":"Bont L, Heijnen CJ, Kavelaars A, van Aalderen WMC, Brus F, Draaisma JTM, Geelen SM, Kimpen JLL: Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study.\nAm J Respir Crit Care Med 2000, 161:1518\u20131523.","journal-title":"Am J Respir Crit Care Med"},{"key":"183_CR10_183","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/(SICI)1099-0496(199706)23:6<397::AID-PPUL1>3.0.CO;2-G","volume":"23","author":"TM Reijonen","year":"1997","unstructured":"Reijonen TM, Korppi M, Kuikka L, Savolainen K, Kleemola M, Mononen I, Remes K: Serum eosinophil cationic protein as a predictor of wheezing after bronchiolitis.\nPediatr Pulmonol 1997, 23:397\u2013403.","journal-title":"Pediatr Pulmonol"},{"key":"183_CR11_183","first-page":"1313","volume-title":"In Fields Virology, 3rd ed, vol. 1","author":"PL Collins","year":"1996","unstructured":"Collins PL, McIntosh K, Chanock RM: Respiratory syncytial virus.\nIn Fields Virology, 3rd ed, vol. 1.\n(Edited by: Edited by Fields BN, Knipe DM, Howley PM). Philadelphia: Lippincott-Raven 1996, 1313\u20131351."},{"key":"183_CR12_183","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0022-3476(99)70154-X","volume":"135","author":"RC Welliver","year":"1999","unstructured":"Welliver RC: Immunologic mechanisms of virus-induced wheezing and asthma.\nJ Pediatr 1999, 135:14\u201320.","journal-title":"J Pediatr"},{"key":"183_CR13_183","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s004310051296","volume":"159","author":"MCJ Kneyber","year":"2000","unstructured":"Kneyber MCJ, Moll HA, de Groot R: Treatment and prevention of respiratory syncytial virus infection.\nEur J Pediatr 2000, 159:399\u2013411.","journal-title":"Eur J Pediatr"},{"key":"183_CR14_183","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ppul.1950090311","volume":"9","author":"C Springer","year":"1990","unstructured":"Springer C, Bar-Yishay E, Uwayyed K, Avital A, Vilozni D, Godfrey S: Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis.\nPediatr Pulmonol 1990, 9:181\u2013185.","journal-title":"Pediatr Pulmonol"},{"key":"183_CR15_183","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0140-6736(96)02285-4","volume":"348","author":"G Roosevelt","year":"1996","unstructured":"Roosevelt G, Sheehan K, Grupp-Phelan J, Tanz RR, Listernick R: Dexamethasone in bronchiolitis; a randomised controlled trial.\nLancet 1996, 348:292\u2013295.","journal-title":"Lancet"},{"key":"183_CR16_183","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0022-3476(97)70342-1","volume":"130","author":"TP Klassen","year":"1997","unstructured":"Klassen TP, Sutcliffe T, Watters LK, Wells GA, Allen UD, Li MM: Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized, controlled trial.\nJ Pediatr 1997, 130:191\u2013196.","journal-title":"J Pediatr"},{"key":"183_CR17_183","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1136\/thx.52.7.634","volume":"52","author":"JBM van Woensel","year":"1997","unstructured":"van Woensel JBM, Wolfs TFW, van Aalderen WMC, Brand PLP, Kimpen JLL: Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis.\nThorax 1997, 52:634\u2013637.","journal-title":"Thorax"},{"key":"183_CR18_183","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/adc.67.3.289","volume":"67","author":"EEL Wang","year":"1992","unstructured":"Wang EEL, Milner R, Allen U, Maj H: Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial.\nArch Dis Child 1992, 67:289\u2013293.","journal-title":"Arch Dis Child"},{"key":"183_CR19_183","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/adc.58.11.925","volume":"58","author":"RL Henry","year":"1983","unstructured":"Henry RL, Milner AD, Stokes GM: Ineffectiveness of ipratropium bromide in acute bronchiolitis.\nArch Dis Child 1983, 58:925\u2013926.","journal-title":"Arch Dis Child"},{"key":"183_CR20_183","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1542\/peds.90.6.920","volume":"90","author":"S Schuh","year":"1992","unstructured":"Schuh S, Johnson D, Canny G, Reisman J, Shields M, Kovesi T, Kerem E, Bentur L, Levison H, Jaffe D: Efficacy of adding nebulized ipratropium bromide to nebulized albuterol therapy in acute bronchiolitis.\nPediatrics 1992, 90:920\u2013923.","journal-title":"Pediatrics"},{"key":"183_CR21_183","first-page":"169","volume":"23","author":"J Seidenberg","year":"1987","unstructured":"Seidenberg J, Masters IB, Hudson I, Olinsky A, Phelan PD: Effect of ipratropium bromide on respiratory mechanics in infants with acute bronchiolitis.\nAust Pediatr J 1987, 23:169\u2013172.","journal-title":"Aust Pediatr J"},{"key":"183_CR22_183","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1542\/peds.100.2.233","volume":"100","author":"G Flores","year":"1997","unstructured":"Flores G, Horwitz RI: Efficacy of \u03b2\n\n                    2\n                  \n-agonists in bronchiolitis: a reappraisal and meta-analysis.\nPediatrics 1997, 100:233\u2013239.","journal-title":"Pediatrics"},{"key":"183_CR23_183","first-page":"286","volume":"24","author":"CB Pinnock","year":"1988","unstructured":"Pinnock CB, Douglas RM, Martin AJ, Badcock NR: Vitamin A status of children with a history of respiratory syncytial virus infection in infancy.\nAust Pediatr J 1988, 24:286\u2013289.","journal-title":"Aust Pediatr J"},{"key":"183_CR24_183","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0166-3542(90)90061-B","volume":"14","author":"PG Higgins","year":"1990","unstructured":"Higgins PG, Barrow GI, Tyrrell DAJ, Isaacs D, Gauci CL: The efficacy of intranasal interferon\u03b1-2a in respiratory syncytial virus infection in volunteers.\nAntiviral Res 1990, 14:3\u201310.","journal-title":"Antiviral Res"},{"key":"183_CR25_183","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0022-3476(88)80263-4","volume":"113","author":"CB Hall","year":"1988","unstructured":"Hall CB, Powell KR, Schnabel KC, Gala CL, Pincus PH: Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial virus infection.\nJ Pediatr 1988, 113:266\u2013271.","journal-title":"J Pediatr"},{"key":"183_CR26_183","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1542\/peds.100.6.937","volume":"100","author":"WJ Rodriguez","year":"1997","unstructured":"Rodriguez WJ, Gruber WC, Groothuis JR, Simoes EAF, Rosas AJ, Lepow M, Kramer A, Hemming V, and the RSV-IGIV Study Group: Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children.\nPediatrics 1997, 100:937\u2013942.","journal-title":"Pediatrics"},{"key":"183_CR27_183","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1542\/peds.99.3.454","volume":"99","author":"WJ Rodriguez","year":"1997","unstructured":"Rodriguez WJ, Gruber WC, Welliver RC, Groothuis JR, Simoes EAF, Meissner HC, Hemming VG, Hall CB, Lepow ML, Rosas AJ, Robertsen C, Kramer AA, for the Respiratory Syncytial Virus Immune Globulin Study Group: Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections.\nPediatrics 1997, 99:454\u2013461.","journal-title":"Pediatrics"},{"key":"183_CR28_183","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","volume":"89","author":"HW Kim","year":"1969","unstructured":"Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, Parrott RH: Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.\nAm J Epidemiol 1969, 89:422\u2013434.","journal-title":"Am J Epidemiol"},{"key":"183_CR29_183","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","volume":"89","author":"AZ Kapikian","year":"1969","unstructured":"Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE: An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine.\nAm J Epidemiol 1969, 89:405\u2013421.","journal-title":"Am J Epidemiol"},{"key":"183_CR30_183","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","volume":"89","author":"VA Fulginiti","year":"1969","unstructured":"Fulginiti VA, Eller JJ, Sieber OF, Joyner JW, Minamitani M, Meiklejohn G: Respiratory virus immunization.\nAm J Epidemiol 1969, 89:435\u2013448.","journal-title":"Am J Epidemiol"},{"key":"183_CR31_183","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/infdis\/170.2.425","volume":"170","author":"RC Welliver","year":"1994","unstructured":"Welliver RC, Tristram DA, Batt K, Sun M, Hogerman D, Hildreth S: Respiratory syncytial virus-specific cell-mediated immune responses after vaccination with a purified fusion protein subunit vaccine.\nJ Infect Dis 1994, 170:425\u2013428.","journal-title":"J Infect Dis"},{"key":"183_CR32_183","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/00006454-199601000-00006","volume":"15","author":"PA Piedra","year":"1996","unstructured":"Piedra PA, Grace S, Jewell A, Spinelli S, Bunting D, Hogerman DA, Malinoski F, Hiatt PW: Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis.\nPediatr Infect Dis J 1996, 15:23\u201331.","journal-title":"Pediatr Infect Dis J"},{"key":"183_CR33_183","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","volume":"329","author":"JR Groothuis","year":"1993","unstructured":"Groothuis JR, Simoes E, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC, Tristram DA, Siber GR, Prince GA, Van Raden M, Hemming VG, for the Respiratory Syncytial Virus Immune Globulin Study Group: Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children.\nN Engl J Med 1993, 329:1524\u20131530.","journal-title":"N Engl J Med"},{"key":"183_CR34_183","first-page":"463","volume":"95","author":"JR Groothuis","year":"1995","unstructured":"Groothuis JR, Simoes EAF, Hemming VG, the Respiratory Syncytial Virus Immune Globulin Study Group: Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG).\nPediatrics 1995, 95:463\u2013467.","journal-title":"Pediatrics"},{"key":"183_CR35_183","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1542\/peds.99.1.93","volume":"99","author":"PREVENT Study Group","year":"1997","unstructured":"PREVENT Study Group: Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis.\nPediatrics 1997, 99:93\u201399.","journal-title":"Pediatrics"},{"key":"183_CR36_183","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1542\/peds.102.3.531","volume":"102","author":"The IMpact-RSV Study Group","year":"1998","unstructured":"The IMpact-RSV Study Group: Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants.\nPediatrics 1998, 102:531\u2013537.","journal-title":"Pediatrics"},{"key":"183_CR37_183","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1164\/ajrccm.163.supplement_1.2011112","volume":"163","author":"EAF Simoes","year":"2001","unstructured":"Simoes EAF: Treatment and prevention of respiratory syncytial virus lower respiratory tract infection.\nAm J Respir Crit Care Med 2001, 163:S14-S17.","journal-title":"Am J Respir Crit Care Med"},{"key":"183_CR38_183","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00006454-199703000-00004","volume":"16","author":"LR Krilov","year":"1997","unstructured":"Krilov LR, Mandel FS, Barone SR, Fagin JC, and the Bronchiolitis Study Group: Follow-up of children with respiratory syncytial virus bronchiolitis in 1986 and 1987: potential effect of ribavirin on long term pulmonary function.\nPediatr Infect Dis J 1997, 16:273\u2013276.","journal-title":"Pediatr Infect Dis J"},{"key":"183_CR39_183","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/00006454-199711000-00004","volume":"16","author":"CE Long","year":"1997","unstructured":"Long CE, Voter KZ, Barker WH, Hall CB: Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo.\nPediatr Infect Dis J 1997, 16:1023\u20131028.","journal-title":"Pediatr Infect Dis J"},{"key":"183_CR40_183","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/archpedi.153.5.469","volume":"153","author":"WJ Rodriguez","year":"1999","unstructured":"Rodriguez WJ, Arrobio J, Fink R, Kim HW, Milburn C: Prospective follow-up and pulmonary functions from a placebo-controlled randomized trial of ribavirin therapy in respiratory syncytial virus bronchiolitis. Ribavirin Study Group.\nArch Pediatr Adolesc Med 1999, 153:469\u2013474.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"183_CR41_183","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/(SICI)1099-0496(199803)25:3<154::AID-PPUL4>3.0.CO;2-M","volume":"25","author":"D Edell","year":"1998","unstructured":"Edell D, Bruce E, Hale K, Edell D, Khoshoo V: Reduced long-term respiratory morbidity after treatment of respiratory syncytial virus bronchiolitis with ribavirin in previously healthy infants: a preliminary report.\nPediatr Pulmonol 1998, 25:154\u2013158.","journal-title":"Pediatr Pulmonol"},{"key":"183_CR42_183","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/00001432-200106000-00013","volume":"14","author":"JLL Kimpen","year":"2001","unstructured":"Kimpen JLL: Management of respiratory syncytial virus infection.\nCurr Opin Infect Dis 2001, 14:323\u2013328.","journal-title":"Curr Opin Infect Dis"},{"key":"183_CR43_183","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1651-2227.2001.tb00301.x","volume":"90","author":"B Hesselmar","year":"2001","unstructured":"Hesselmar B, Adolfsson S: Inhalation of corticosteroids after hospital care for respiratory syncytial virus infection diminishes development of asthma in infants.\nActa Paediatr 2001, 90:260\u2013263.","journal-title":"Acta Paediatr"},{"key":"183_CR44_183","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1034\/j.1399-3038.2000.00068.x","volume":"11","author":"M Kajosaari","year":"2000","unstructured":"Kajosaari M, Syvanen P, Forars M, Juntunen-Backman K: Inhaled corticosteroids during and after respiratory syncytial virus-bronchiolitis may decrease subsequent asthma.\nPediatr Allergy Immunol 2000, 11:198\u2013202.","journal-title":"Pediatr Allergy Immunol"},{"key":"183_CR45_183","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/archpedi.1996.02170300066013","volume":"150","author":"T Reijonen","year":"1996","unstructured":"Reijonen T, Korppi M, Kuikka L, Remes K: Anti-inflammatory therapy reduces wheezing after bronchiolitis.\nArch Pediatr Adolesc Med 1996, 150:512\u2013517.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"183_CR46_183","first-page":"1066","volume":"92","author":"J-L Huang","year":"1993","unstructured":"Huang J-L, Hung I-J, Hsieh K-H: Effect of inhaled beclomethasone dipropionate in the treatment of recurrent wheezing in infancy and early childhood.\nJ Formos Med Assoc 1993, 92:1066\u20131069.","journal-title":"J Formos Med Assoc"},{"key":"183_CR47_183","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1136\/adc.82.2.126","volume":"82","author":"A Cade","year":"2000","unstructured":"Cade A, Brownlee KG, Conway SP, Haigh D, Short A, Brown J, Dassu D, Mason SA, Phillips A, Eglin R, Graham M, Chetcuti A, Chatrath M, Hudson N, Thomas A, Chetcuti PAJ: Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis.\nArch Dis Child 2000, 82:126\u2013130.","journal-title":"Arch Dis Child"},{"key":"183_CR48_183","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1542\/peds.106.6.1406","volume":"106","author":"TM Reijonen","year":"2000","unstructured":"Reijonen TM, Kotaniemi-Syrjanen A, Korhonen K, Korppi M: Predictors of asthma three years after hospital admission for wheezing in infancy.\nPediatrics 2000, 106:1406\u20131412.","journal-title":"Pediatrics"},{"key":"183_CR49_183","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/1099-0496(200008)30:2<92::AID-PPUL3>3.0.CO;2-X","volume":"30","author":"JBM van Woensel","year":"2000","unstructured":"van Woensel JBM, Kimpen JLL, Sprikkelman AB, Ouwehand A, van Aalderen WMC: Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus.\nPediatr Pulmonol 2000, 30:92\u201396.","journal-title":"Pediatr Pulmonol"},{"key":"183_CR50_183","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/adc.80.4.343","volume":"80","author":"GF Fox","year":"1999","unstructured":"Fox GF, Everard ML, Marsh MJ, Milner AD: Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing.\nArch Dis Child 1999, 80:343\u2013347.","journal-title":"Arch Dis Child"},{"key":"183_CR51_183","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/(SICI)1099-0496(199809)26:3<162::AID-PPUL2>3.0.CO;2-N","volume":"26","author":"I Berger","year":"1998","unstructured":"Berger I, Argaman Z, Schwartz SB, Segal E, Kiderman A, Branski D, Kerem E: Efficacy of corticosteroids in acute bronchiolitis: short-term and long-term follow-up.\nPediatr Pulmonol 1998, 26:162\u2013166.","journal-title":"Pediatr Pulmonol"},{"key":"183_CR52_183","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0022-3476(98)70316-6","volume":"132","author":"H Richter","year":"1998","unstructured":"Richter H, Seddon P: Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing.\nJ Pediatr 1998, 132:849\u2013853.","journal-title":"J Pediatr"},{"key":"183_CR53_183","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s004310051295","volume":"159","author":"J van Woensel","year":"2000","unstructured":"van Woensel J, Kimpen J: Therapy for respiratory tract infections caused by respiratory syncytial virus.\nEur J Pediatr 2000, 159:391\u2013398.","journal-title":"Eur J Pediatr"},{"key":"183_CR54_183","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0002-9343(02)01095-1","volume":"112","author":"SE Wenzel","year":"2002","unstructured":"Wenzel SE, Gibbs RL, Lehr MV, Simoes EAF: Respiratory outcomes in high-risk children 7 to 10 years after prophylaxis with respiratory syncytial virus immune globulin.\nAm J Med 2002, 112:627\u2013633.","journal-title":"Am J Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/rr183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/rr183\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/rr183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/rr183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T15:33:16Z","timestamp":1714059196000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/rr183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6,24]]},"references-count":54,"journal-issue":{"issue":"S1","published-online":{"date-parts":[[2002,6]]}},"alternative-id":["183"],"URL":"https:\/\/doi.org\/10.1186\/rr183","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6,24]]},"assertion":[{"value":"28 May 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"2"}}